Danopharm Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2009.
2009 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Danopharm Private Limited

Danopharm Private Limited, a active private limited company, was established on 15 January 2009 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24100MH2009PTC189592. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹2.00 Cr.

Formerly known as Danopharm Chemicals Limited, Danopharm Private Limited. It upholds a compliant status. Employing 85 professional, Its leadership includes Jayanta Badalchandra Das (Director), Kamlesh Badal Das (Director), Satish Prabhakar Nachane (Director). Past directors included Satish Prabhakar Nachane, Mehul Satish Nachane. It holds ₹21.18 Cr open charges and ₹11.25 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Unit No 117, Ravi Kiran, 1St Floor, Near Monginis, Off New Link Road, Andheri(West), Mumbai, Maharashtra, 400053.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100MH2009PTC189592

  • Registration Number

    189592

  • Incorporation Date

    15 January 2009

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹2.00 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 2.00 Cr
  • Company Age 17 Year, 1 Month
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 21.18 Cr
  • Satisfied Charges ₹ 11.25 Cr
  • Revenue Growth **** 5.67%
  • Profit Growth **** -36.83%
  • Ebitda **** -24.07%
  • Net Worth 16.26%
  • Total Assets -1.65%
Company report

Danopharm Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Danopharm Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Danopharm Private Limited?
Current Directors
Name Designation Appointment Date Status
Jayanta Badalchandra Das Director 15 Jan 2009 Current
Kamlesh Badal Das Director 15 Jan 2009 Current
Satish Prabhakar Nachane Director 03 Sep 2009 Current
Ramesh Eknath Jadhav Director 16 Mar 2010 Current
Sabu Daniel Director 16 Mar 2010 Current
Kashinath Badal Das Director 15 Jan 2009 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 31 Jul 2010 Past
Pramod Abcsdd Additional Director 31 Jul 2010 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Danopharm.

Danopharm Chemicals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.67% increase. The company also saw a substantial fall in profitability, with a 36.83% decrease in profit. The company's net worth Soared by an impressive increase of 16.26%.

Danopharm revenue growth over time
Danopharm profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 5.67%
*******
*******
*******
*******
Revenue from Operations
*******
 5.29%
*******
*******
*******
*******
Total Assets
*******
 -1.65%
*******
*******
*******
*******
Profit or Loss
*******
 -36.83%
*******
*******
*******
*******
Net Worth
*******
 16.26%
*******
*******
*******
*******
EBITDA
*******
 -24.07%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Danopharm?

In 2023, Danopharm had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹211,800,000.00

Satisfied Charges

₹112,500,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 21.18 Cr
Latest Charge Details
Date Lender Amount Status
21 Jul 2011 State Bank Of India ₹21.18 Cr Open
15 Sep 2009 United Bank Of India ₹11.25 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Danopharm?

Danopharm has a workforce of 85 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Danopharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Danopharm's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Danopharm
Recent Activity within the Organization
  • Annual General Meeting

    Danopharm Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Danopharm Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.

  • Charges

    Progress on A charge with State Bank Of India of Rs. 21.18 Cr registered on 21 Jul 2011 with Charge ID 10302455 was modified on 03 Aug 2023. was documented.

  • Charges

    The activity A charge registered on 15 Sep 2009 via Charge ID 10177240 with United Bank Of India was fully satisfied on 15 Jun 2012. was completed.

  • Charges

    A charge with State Bank Of India amounted to Rs. 21.18 Cr with Charge ID 10302455 was registered on 21 Jul 2011. was recorded as a recent event.

  • Charges

    A charge with United Bank Of India of Rs. 11.25 Cr registered on 15 Sep 2009 with Charge ID 10177240 was modified on 23 Sep 2010. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Danopharm Private Limited?

The CIN of Danopharm Private Limited is U24100MH2009PTC189592.

Where is Danopharm Private Limited headquartered?

Danopharm Private Limited is headquartered at Unit No 117, Ravi Kiran, 1St Floor, Near Monginis, Off New Link Road, Andheri(West), Mumbai, Maharashtra, 400053.

When was Danopharm Private Limited incorporated?

Danopharm Private Limited was incorporated on 15 January 2009.

Who are the current directors of Danopharm Private Limited?

The current directors of Danopharm Private Limited are

What is the primary industry of Danopharm Private Limited?

The primary industry of Danopharm Private Limited is Manufacturing.

Is Danopharm Private Limited a listed company?

Danopharm Private Limited is unlisted.

What is the capital structure of Danopharm Private Limited?

The authorized capital of Danopharm Private Limited is ₹2.00 Cr, and the paid-up capital is ₹2.00 Cr.

What is the compliance status of Danopharm Private Limited?

The compliance status of Danopharm Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available